SCHEMBL13734744

SCHEMBL13734744

OC(/C=C/c1ccccc1)(c1ccc(Cl)cc1)C(F)(F)F

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1B1 Q16678 2/20 0.41
CNR1 P21554 2/20 0.41
MAPT P10636 3/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
ALDH1A1 P00352 3/20 0.39
GRIN1 Q05586 3/20 0.39
GRIN2B Q13224 3/20 0.39
LMNA P02545 2/20 0.39
S1PR4 O95977 1/20 0.39
S1PR1 P21453 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
MAOB P27338 2/20 0.39
EGFR P00533 2/20 0.39
PPARG P37231 1/20 0.39
CYP1A1 P04798 1/20 0.39
MMP1 P03956 1/20 0.39
MMP2 P08253 1/20 0.39
MMP9 P14780 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.37
MEN1 O00255 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13734748 1.00 CYP1B1 (0.41) CYP1B1CNR1MAPTL3MBTL1ALDH1A1
SCHEMBL13736516 0.88 ALDH1A1 (0.47) CYP1B1MAPTALDH1A1GRIN1GRIN2B
SCHEMBL13734851 0.88 ALDH1A1 (0.47) CYP1B1MAPTALDH1A1GRIN1GRIN2B
SCHEMBL15497447 0.81 GRIN1 (0.44) CYP1B1MAPTALDH1A1GRIN1GRIN2B
SCHEMBL13736472 0.81 TRPA1 (0.54) CYP1B1MAPTALDH1A1LMNAMAOB
SCHEMBL13736125 0.81 TRPA1 (0.54) CYP1B1MAPTALDH1A1LMNAMAOB
SCHEMBL13735449 0.78 CYP1B1 (0.49) CYP1B1MAPTALDH1A1LMNANPSR1
SCHEMBL13735453 0.78 CYP1B1 (0.49) CYP1B1MAPTALDH1A1LMNANPSR1
SCHEMBL13734790 0.76 CYP1A1 (0.45) CYP1B1MAOBCYP1A1NFE2L2
SCHEMBL13734791 0.76 CYP1A1 (0.45) CYP1B1MAOBCYP1A1NFE2L2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9334253-B2 Direct trifluoromethylations using trifluoromethane UNIVERSITY OF SOUTHERN CALIFORNIA (US) 2016-05-10 US claimed
US-20140066640-A1 DIRECT TRIFLUOROMETHYLATIONS USING TRIFLUOROMETHANE UNIVERSITY OF SOUTHERN CALIFORNIA (US) 2014-03-06 US claimed
WO-2012148772-A1 DIRECT TRIFLUOROMETHYLATIONS USING TRIFLUOROMETHANE UNIVERSITY OF SOUTHERN CALIFORNIA (US) 2012-11-01 WO claimed
EP-2712367-B1 DIRECT TRIFLUOROMETHYLATIONS USING TRIFLUOROMETHANE UNIV SOUTHERN CALIFORNIA (US) 2018-09-26 EP disclosed
US-9334253-B2 Direct trifluoromethylations using trifluoromethane UNIVERSITY OF SOUTHERN CALIFORNIA (US) 2016-05-10 US disclosed
US-9334253-B2 Direct trifluoromethylations using trifluoromethane UNIVERSITY OF SOUTHERN CALIFORNIA (US) 2016-05-10 US disclosed
US-9334253-B2 Direct trifluoromethylations using trifluoromethane UNIVERSITY OF SOUTHERN CALIFORNIA (US) 2016-05-10 US disclosed
US-20140066640-A1 DIRECT TRIFLUOROMETHYLATIONS USING TRIFLUOROMETHANE UNIVERSITY OF SOUTHERN CALIFORNIA (US) 2014-03-06 US disclosed
US-20140066640-A1 DIRECT TRIFLUOROMETHYLATIONS USING TRIFLUOROMETHANE UNIVERSITY OF SOUTHERN CALIFORNIA (US) 2014-03-06 US disclosed
US-20140066640-A1 DIRECT TRIFLUOROMETHYLATIONS USING TRIFLUOROMETHANE UNIVERSITY OF SOUTHERN CALIFORNIA (US) 2014-03-06 US disclosed
WO-2012148772-A1 DIRECT TRIFLUOROMETHYLATIONS USING TRIFLUOROMETHANE UNIVERSITY OF SOUTHERN CALIFORNIA (US) 2012-11-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140066640-A1 DIRECT TRIFLUOROMETHYLATIONS USING TRIFLUOROMETHANE TST, FLI1, CYP2F1 CYP1B1 1586/4885CNR1 4425/4885MAPT 3128/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.